semaglutide vs tirzepatide español vs. Semaglutide: Which Works Best? Semaglutide vs Tirzepatide 💉⚖️ Both

A new direction in weight management Advances in medical science continue to transform the way weight management is approached

Ladebo, L

Pi-Sunyer, X

In late April 2022, Eli Lilly released preliminary results from the SURMOUNT-1 trial that included overweight and obese patients using tirzepatide who did not have diabetes

The late-stage trial on tirzepatide, the active ingredient in the company's weight loss injection Zepbound and diabetes drug Mounjaro, also found that patients experienced sustained weight loss over the roughly three-year treatment period

GIPs effects on appetite and brain signaling are less clear than GLP-1s